Skip to main content

Year: 2024

Wintrust Financial Corporation Reports Third Quarter and Year-to-Date Results

ROSEMONT, Ill, Oct. 21, 2024 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”, “the Company”, “we” or “our”) (Nasdaq: WTFC) announced net income of $509.7 million or $7.67 per diluted common share for the first nine months of 2024 compared to net income of $499.1 million or $7.71 per diluted common share for the same period of 2023. Pre-tax, pre-provision income (non-GAAP) for the first nine months of 2024 totaled a record $778.1 million, compared to $751.3 million in the first nine months of 2023. The Company recorded quarterly net income of $170.0 million or $2.47 per diluted common share for the third quarter of 2024 compared to net income of $152.4 million or $2.32 per diluted common share for the second quarter of 2024. Pre-tax, pre-provision income (non-GAAP) totaled $255.0 million as compared to $251.4 million...

Continue reading

HUHUTECH International Group Inc. Announces Pricing of Initial Public Offering

Wuxi, China, Oct. 21, 2024 (GLOBE NEWSWIRE) — HUHUTECH International Group Inc. (the “Company” or “HUHUTECH”), a professional provider of factory facility management and monitoring systems, today announced the pricing of its initial public offering (the “Offering”) of 1,050,000 ordinary shares (“Ordinary Shares”) at a public offering price of US$4.0 per Ordinary Share. The Ordinary Shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on October 22, 2024 under the ticker symbol “HUHU.” The Company expects to receive aggregate gross proceeds of US$4.2 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 157,500 Ordinary Shares at the public...

Continue reading

Churchill Announces Shares for Debt Transaction

TORONTO, Oct. 21, 2024 (GLOBE NEWSWIRE) — Further to its news release dated March 6, 2023 announcing the exercise of an existing option to acquire a 100% interest in certain mineral properties with prospective diamond targets plus potential nickel and lithium targets located immediately west of the town of White River, Ontario (the “Properties”), Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) announces that it has agreed to settle an outstanding debt in the amount of $50,000 (the “Debt”), representing an annual advance royalty owing to the vendors of the Properties under the terms of an existing option and purchase agreement, by issuing an aggregate of 555,555 common shares of the Company (“Common Shares”) at a price of $0.09 per Common Share to the vendors (the “Shares for Debt Transaction”). The Board of...

Continue reading

Inspirato to Announce Third Quarter 2024 Results Monday, October 28

DENVER, Oct. 21, 2024 (GLOBE NEWSWIRE) — Inspirato Incorporated (NASDAQ: ISPO) (the “Company”), the premier luxury vacation club, today announced plans to release its third quarter 2024 financial and operating results after market close on Monday, October 28.   The Company will host a conference call on Tuesday, October 29, to discuss the results. To listen to the audio webcast and Q&A, please visit the Inspirato Investor Relations website at https://investor.inspirato.com or use the webcast link below. An audio replay of the webcast will be available on the Inspirato Investor Relations website shortly after the call. Conference Call and Webcast:Date/Time: Tuesday, October 29, 2024 at 11:00 a.m. ETWebcast: https://edge.media-server.com/mmc/p/o37vkjho About Inspirato Inspirato (NASDAQ: ISPO) is a members-only luxury vacation...

Continue reading

GRI Bio Announces Exercise of Warrants

LA JOLLA, CA, Oct. 21, 2024 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that it has entered into definitive agreements for the exercise of certain existing warrants to purchase an aggregate of 762,236 shares of the Company’s common stock, having an original exercise price of $14.30 per share, originally issued by GRI Bio in February 2024, at a reduced exercise price of $1.00 per share. The issuance of the shares of common stock issuable upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-1 (File No. 333-276205). The offering is expected to close on or about...

Continue reading

Firan Technology Group Corporation to Acquire FLYHT Aerospace Solutions Ltd.

TORONTO, Oct. 21, 2024 (GLOBE NEWSWIRE) — Firan Technology Group Corporation (TSX: FTG) (“FTG” or the “Corporation”) is pleased to announce that it has entered into a definitive arrangement agreement (the “Agreement”) with FLYHT Aerospace Solutions Ltd. (“FLYHT”) to acquire all of the issued and outstanding shares of FLYHT (the “FLYHT Shares”) under a plan of arrangement under the Canada Business Corporations Act (the “Transaction”). Under the terms of the Transaction, FLYHT shareholders may elect to receive in exchange for each FLYHT Share, (i) CAD$0.1103 in cash and 0.0333 of a common share of FTG (each whole such share, an “FTG Share”), (ii) CAD$0.3379 in cash or (iii) 0.0495 FTG Shares, subject to pro-ration (collectively, the “Consideration”). The Consideration will be subject to a total maximum cash consideration of CAD$4.3...

Continue reading

First Helium Announces Upsize of Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Oct. 21, 2024 (GLOBE NEWSWIRE) — First Helium Inc. (“First Helium” or the “Company”) (TSXV: HELI) (OTCQB: FHELF) (FRA: 2MC) is pleased to announce its intention to increase the size of its previously announced non-brokered private placement financing (October 16, 2024) from C$2,500,000 to C$3,000,000. The Company will now issue up to 50,000,000 Units of the Company (“Units”) at a price of $0.06 per Unit, for aggregate gross proceeds of C$3,000,000. Each Unit will be comprised of one common share in the capital of the Company (a “Share”) and one transferrable common share purchase warrant (a “Warrant”). Each Warrant will be exercisable to acquire one Share at a price of $0.09 cents per Share for a period of 36 months from the...

Continue reading

Summa Silver Announces $5 Million Brokered Financing

VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) — Summa Silver Corp. (“Summa” or the “Company”) (TSXV:SSVR) (OTCQX:SSVRF) (Frankfurt:48X) is pleased to announce that it has entered into an agreement with Research Capital Corporation and Eventus Capital Corp., as co-lead agents and joint bookrunners, on behalf of a syndicate of agents (collectively, the “Agents“) in connection with a brokered private placement (the “Offering“) of up to 12,500,000 units (each, a “Unit”) at a price of $0.40 per Unit, for aggregate gross proceeds of up to $5 million. Each Unit will be comprised of one common share of the Company (a “Common Share”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”). Each whole Warrant shall be exercisable to acquire one Common Share at a price of $0.55 per Common Share for...

Continue reading

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform learned earlier this morning that Eli Lilly has made certain public claims alleging, and has stated that it has filed a lawsuit against MangoRx claiming, that MangoRx improperly copied its weight-loss medicine, Zepbound and Mounjaro. MangoRx strongly refutes any and all claims made by Eli Lilly regarding the sale of compounded tirzepatide. MangoRx believes it has strong arguments against Eli Lilly’s claims and intends to vigorously defend itself in this matter. MangoRx’s focus is, and will continue to be, providing access to safe and efficacious products to serve patients who have been deemed...

Continue reading

Monroe Capital Corporation Schedules Third Quarter 2024 Earnings Release and Conference Call

CHICAGO, Oct. 21, 2024 (GLOBE NEWSWIRE) — Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that it will report its third quarter ended September 30, 2024 financial results on Tuesday, November 12, 2024, after the close of the financial markets. The Company will host a webcast and conference call to discuss these operating and financial results on Wednesday, November 13, 2024 at 11:00 a.m. Eastern Time. The webcast will be hosted on a webcast link located in the Investor Relations section of our website at http://ir.monroebdc.com/events.cfm. To participate in the conference call, please dial (800) 715-9871 approximately 10 minutes prior to the call. Please reference conference ID # 5769748. For those unable to listen to the live broadcast, the webcast will be available for replay on the Company’s website...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.